Drug information for ABSTRAL
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; SUBLINGUAL
EQ 0.1MG BASE
Prescription
FENTANYL CITRATE
Fentanyl
PROSTRAKAN INC
22510
2012-01-06 Label
2012-01-03 Letter
2011-11-02 Review
2011-11-02 Summary Review
2011-01-14 Other
2011-01-14 Letter
2011-01-13 Medication Guide
2011-01-10 Label
TABLET; SUBLINGUAL
EQ 0.2MG BASE
Prescription
FENTANYL CITRATE
Fentanyl
PROSTRAKAN INC
"
TABLET; SUBLINGUAL
EQ 0.3MG BASE
Prescription
FENTANYL CITRATE
Fentanyl
PROSTRAKAN INC
"
TABLET; SUBLINGUAL
EQ 0.4MG BASE
Prescription
(Reference Drug)
FENTANYL CITRATE
Fentanyl
PROSTRAKAN INC
"
TABLET; SUBLINGUAL
EQ 0.6MG BASE
Prescription
FENTANYL CITRATE
Fentanyl
PROSTRAKAN INC
"
TABLET; SUBLINGUAL
EQ 0.8MG BASE
Prescription
FENTANYL CITRATE
Fentanyl
PROSTRAKAN INC
"
Drug Adverse Effects information for ABSTRAL
Role code
Indications
Reaction
# Reports
PS
BACK PAIN
BREAKTHROUGH PAIN
1
PS
BACK PAIN
MULTIPLE DRUG OVERDOSE
1
PS
BACK PAIN
NEUROLOGICAL SYMPTOM
1
PS
BACK PAIN
OFF LABEL USE
1
PS
BACK PAIN
SOMNOLENCE
1
PS
BACK PAIN
TOXICITY TO VARIOUS AGENTS
1
PS
BREAKTHROUGH PAIN
DRUG INEFFECTIVE
1
PS
BREAKTHROUGH PAIN
INTENTIONAL DRUG MISUSE
2
PS
BREAKTHROUGH PAIN
NO ADVERSE EVENT
2
PS
BREAKTHROUGH PAIN
OFF LABEL USE
1
PS
BREAKTHROUGH PAIN
PRODUCT QUALITY ISSUE
1
PS
PAIN
BREAKTHROUGH PAIN
2
PS
PAIN
MULTIPLE DRUG OVERDOSE
2
PS
PAIN
NEUROLOGICAL SYMPTOM
2
PS
PAIN
OFF LABEL USE
2
PS
PAIN
SOMNOLENCE
2
PS
PAIN
TOXICITY TO VARIOUS AGENTS
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
DEATH
1
SS
BREAKTHROUGH PAIN
INTENTIONAL DRUG MISUSE
2
SS
BREAKTHROUGH PAIN
NO ADVERSE EVENT
2
SS
PAIN
DRUG INEFFECTIVE
7
SS
PAIN
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
4
SS
PAIN
NEUROLOGICAL SYMPTOM
3
SS
PAIN
OVERDOSE
3
SS
PAIN
SOMNOLENCE
3
SS
PAIN
TOXICITY TO VARIOUS AGENTS
3
SS
PAIN
TREATMENT NONCOMPLIANCE
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INEFFECTIVE
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
NEUROLOGICAL SYMPTOM
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
OVERDOSE
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
SOMNOLENCE
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
TOXICITY TO VARIOUS AGENTS
3
C
DIABETES MELLITUS
MUSCULAR WEAKNESS
1
C
DIABETES MELLITUS
TUMOUR PAIN
1
C
HYPOTENSION
MUSCULAR WEAKNESS
2
C
HYPOTENSION
TUMOUR PAIN
2
C
PROSTATE CANCER METASTATIC
MUSCULAR WEAKNESS
2
C
PROSTATE CANCER METASTATIC
TUMOUR PAIN
2
C
TUMOUR PAIN
MUSCULAR WEAKNESS
4
C
TUMOUR PAIN
TUMOUR PAIN
4
Ads by Google